Capital CS Group’s Eton Pharmaceutcials ETON Stock Holding History

Capital CS Group’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$453K	Buy	+8,807	New	+$447K	0.34%	42

Other funds holding ETON

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Capital CS Group's ETON Position: Q3 2026 in Review

Capital CS Group opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 8,807 shares worth $453K. The stake represents 0.34% of the portfolio and ranks #42 among its holdings.

84 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

Capital CS Group held 8,807 shares of Eton Pharmaceutcials worth $453K as of Q3 2026.
Eton Pharmaceutcials was a new Capital CS Group position in Q3 2026.
Eton Pharmaceutcials made up 0.34% of Capital CS Group's portfolio in Q3 2026, its #42 holding.
84 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Capital CS Group's 13F filing for Q3 2026, filed 29 Oct 2026.